Nuveen Asset Management’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-77,379
| Closed | -$175K | – | 3262 |
|
|
2023
Q1 | $175K | Sell |
77,379
-2,779
| -3% | -$6.29K | ﹤0.01% | 3005 |
|
|
2022
Q4 | $280K | Sell |
80,158
-5,951
| -7% | -$20.8K | ﹤0.01% | 3000 |
|
|
2022
Q3 | $3.19M | Sell |
86,109
-672
| -0.8% | -$24.9K | ﹤0.01% | 2148 |
|
|
2022
Q2 | $1.65M | Buy |
86,781
+15,782
| +22% | +$300K | ﹤0.01% | 2536 |
|
|
2022
Q1 | $1.62M | Buy |
70,999
+12,333
| +21% | +$281K | ﹤0.01% | 2606 |
|
|
2021
Q4 | $1.32M | Sell |
58,666
-2,049
| -3% | -$46.1K | ﹤0.01% | 2749 |
|
|
2021
Q3 | $1.59M | Buy |
60,715
+2,427
| +4% | +$63.6K | ﹤0.01% | 2783 |
|
|
2021
Q2 | $1.87M | Sell |
58,288
-3,583
| -6% | -$115K | ﹤0.01% | 2748 |
|
|
2021
Q1 | $2.18M | Buy |
61,871
+2,469
| +4% | +$87K | ﹤0.01% | 2577 |
|
|
2020
Q4 | $1.91M | Buy |
59,402
+5,638
| +10% | +$181K | ﹤0.01% | 2538 |
|
|
2020
Q3 | $2.02M | Sell |
53,764
-3,520
| -6% | -$132K | ﹤0.01% | 2382 |
|
|
2020
Q2 | $2.56M | Buy |
+57,284
| New | +$2.56M | ﹤0.01% | 2231 |
|